塔落岩黄芪、细枝岩黄芪及其变异型的生理特性研究

本文研究了毛乌素沙漠地区塔落岩黄芪和细枝岩黄芪及其变异型的生理学特性。结果表明,塔落岩黄芪和细枝岩黄芪各与其变异型之间在生理特性方面存在着极其显著的差异。     

丝素膜的结构测定和分析

对脱胶丝素纤维、初生丝素蛋白膜、固定化ＧＯＤ－丝素膜结构进行了红外光谱分析。三者红外光谱图差异明显，丝素纤维为典型的丝Ⅱ（双向平行的β片层）结构，初生丝素膜的红外光谱显示无规卷曲或丝Ⅰ构型的特征，经戊二醛活化处理后制备的酶膜，在７００ｃｍ－１处有一显著吸收峰，表明其构型向β型转变，丝素膜的水溶率变化也证实了红外光谱显示的结果。     

Synergistic effects of Miconazole and Polymyxin B on microbial pathogens

The therapeutic value of antibiotics depends on the susceptibility of the infecting microorganism and the pharmacological profile of the drugs. To assess the value of an antibiotic combination of polymyxin B and miconazole this study examined the in vitro synergistic potential of the two drugs on Gram-negative and Gram-positive bacteria and yeast. Antifungal and antibacterial activity was tested by minimum inhibitory concentration (MIC) of broth macrodilution and urea broth microdilution, by fluorescence microscopy and flow cytometry. Synergism was calculated using the fractional inhibitory concentration index (FICi). With Staphylococcus intermedius as target we found up to an eightfold reduction of the individual MICs when both drugs were combined. However, the FICi was 0.63 suggesting no real interaction between the two drugs. With Escherichia coli, Pseudomonas aeruginosa, and Malassezia pachydermatis as targets the antimicrobial drug combination reduced the MICs of polymyxin B and miconazole from fourfold to hundredfold resulting in FICi between 0.06 and 0.5 which defines a synergistic action. Thus, if polymyxin B and miconazole are combined their effect is greater than the sum of the effects observed with polymyxin B and miconazole independently, revealing bactericidal and fungicidal synergism. Our results indicate a strong therapeutic value for the combination of these antimicrobial agents against Gram-negative bacteria and yeast and a weaker value against Gram positive bacteria for clinical situations where these pathogens are involved.     

郁金散加减方对长白猪传染性胃肠炎治疗效果的研究

为了研究郁金散加减方对长白猪传染性胃肠炎的治疗效果,从张家口顺德猪场选取患有传染性胃肠炎的成年长白猪20头,随机分为郁金散加减方低剂量组、郁金散加减方高剂量组、西药组和对照组,每组各5头。郁金散加减方组每天灌服郁金散方剂,早晚各1次,低、高剂量组分别按6、7mL/kg体重给药;西药组每天灌服金刚乙胺,颈部皮下注射氟苯尼考,早晚各1次;对照组正常饲喂,不给药。7d后观察临床症状和生长性能,测定血常规、血清生化指标、血清免疫指标及抗氧化指标。结果表明:郁金散加减方组和西药组病猪反应灵敏,体温正常,进食量增加,粪便恢复正常。低、高剂量组和西药组治愈率分别为80%、90%和60%,郁金散加减方的治疗效果优于西药治疗。与对照组相比,高剂量组能极显著提高猪平均日增重(ADG)和平均日采食量(ADFI)(P<0.01),极显著降低料重比(P<0.01);3个给药组均能极显著降低血尿素氮(BUN)、丙二醛(MDA)和白细胞数量(WBC)(P<0.01),极显著提高血清钾(K)、总蛋白(TP)、白蛋白(ALB)、球蛋白(GLB)含量和总抗氧化能力(T-AOC)(P<0.01),但3组间差异不显著(P>0.05);高剂量组过氧化氢酶(CAT)活性极显著高于低剂量组、西药组和对照组(P<0.01)。表明郁金散加减方对长白猪传染性胃肠炎有较好的治疗效果,其中郁金散加减方高剂量组效果更好。     

<Emphasis Type="Italic">Streptococcus uberis</Emphasis>-specific T cells are present in mammary gland secretions of cows and can be activated to kill <Emphasis Type="Italic">S. uberis</Emphasis>

The presence, phenotype and function of Streptococcus uberis-specific T cells in the mammary gland secretion (MGS) and blood of cows exposed to S. uberis were assessed. MGS T cells in the udder were purified and incubated with autologous blood monocytes as antigen-presenting cells (APC). Most cows, irrespective of prior S. uberis infection status and lactation status, were shown to have S. uberis-specific T cells both in MGS and in the blood. When cells from a subgroup of cows were studied, it was found that the S. uberis-specific T cells produced high levels of interferon-gamma (IFN-γ), but low levels of interleukin-10 (IL-10). A high percentage of responding T cells were of the CD8 ⁺ memory (CD45RO) subset. T cells from the MGS specific for S. uberis were propagated from animals during the drying off period and expanded in vitro using interleukin-2 (IL-2) and S. uberis antigens. This led to the accumulation of T cells of the CD8 ⁺ subset bearing memory cell markers (CD45A ⁻ , CD45RO ⁺ ), which released high levels of IFN-γ. Four of the five T cell lines derived from the MGS of three animals had substantial direct killing activity towards S. uberis in vitro. It is concluded that there is an emergence of S. uberis-specific bactericidal T cells in the MGS of cows after infection or environmental exposure to S. uberis. Vaccines aimed at activating and expanding this T cell population in the mammary glands of cattle may offer an avenue for the prevention of mastitis caused by S. uberis.     

畜禽养殖场环境微生物致病性和耐药性调查研究

为了解掌握养殖场中环境微生物对养殖业和公共卫生造成的影响,初步对我国养殖场环境微生物进行了研究。对吉林、湖北等省份的部分养猪场和养鸡场环境采样,并进行大肠杆菌和沙门氏菌分离鉴定,同时对从鸡舍和猪舍内分离大肠杆菌和沙门氏菌进行动物致病性实验及对13种抗生素的耐药性实验。实验结果表明,所有实验的沙门氏菌和90.7%的大肠杆菌菌株对小白鼠有致病性;所有分离菌株对磺胺类药物的耐药性非常严重,其次是对四环素,对其他药物也有不同程度的耐药性。     

不同来源微粒子孢子间血清学关系的比较研究

应用玻片凝集法和酶标抗体法比较了几种不同来源微粒子孢子间的血清学关系，包括本所保存的家蚕微粒子孢子（ＢｍＮ．ｂ），从安徽绩溪和江苏东台的饲养蚕中收集到的微粒子孢子和从四川收集到的蓝叶虫（ｐｈｙｌｌｏｂｒｏｔｉａｃａｒｍａｔａＢａｌｙ）微粒子孢子。结果表明，绩溪、东台微粒子孢子与ＢｍＮ．ｂ之间具有相同的血清学关系，而蓝叶虫微粒子孢子与ＢｍＮ．ｂ之间无血清学关系。     

Regulation of fibroblast growth factor 9 on the differentiation of goat intramuscular adipocytes

It has been found that fibroblast growth factor receptor (FGF-FGFR) signaling can regulate the expression of adipocyte differentiation genes. FGF9 is one of the members of FGFs that mainly binds receptors FGFR2 and FGFR3. FGF9 is highly expressed in the adipose tissue of humans and mice, but there are few reports on the role of FGF9 in goat intramuscular adipocyte differentiation. Therefore, this study explored the effect of FGF9 on adipocyte differentiation through cell culture, interference, and overexpression. The expression of receptors FGFR1–FGFR4 in adipocyte differentiation and their effects on differentiation were detected to screen receptor gene of FGF9. Finally, the interaction between FGF9 and the receptor was tested by cotransfection. Our results showed that FGF9 interacts with FGFR2 to inhibit goat intramuscular adipocyte differentiation by regulating peroxisome proliferator-activated receptor gamma (PPARγ) and preadipocyte factor 1 (Pref1), which is a data support for subsequent pathway research.     

购犬应当选择好的繁殖者

当养犬爱好者想给自己挑选一头爱犬时,怎样选择小犬将会是一个至关重要的问题.笔者认为,了解小犬的饲养繁殖者很重要.因为小犬的饲养繁殖者直接关系到犬的质量.……     

蜂王浆的抗菌活性研究

本文采用平板培养法研究蜂王浆的抗菌活性 ,发现新鲜蜂王浆对10种试验菌均有不同程度的抑制作用。根据抑菌斑的大小判断 ,蜂王浆对各种试验菌株的抑制程度为 :枯草杆菌>威克氏酵母>蜡状芽孢杆菌>隐球酵母>鼠伤寒沙门氏菌>大肠杆菌O111>福氏志贺氏2型菌>假单孢杆菌>N1 米曲霉>霉菌W15。